← Back to headlines
BMO Capital Cuts Price Target on BioNTech SE (BNTX)
BMO Capital has reduced its price target for BioNTech SE (BNTX) from $143 to $128.
31 Mar, 15:06 — 31 Mar, 15:06
Sources
Showing 1 of 1 sources
BMO Capital has reduced its price target for BioNTech SE (BNTX) from $143 to $128.
